Abstract Library

#2825 Interest of PET-MRI in the Management of GIT NETs

Introduction: Assessment of GIT NET requires different imaging exams including CT, MRI, Scintigraphy. The hybrid PET-CT machine impacted the management of TNEs. The whole body PET-MRI version is available but poorly evaluated.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Tannoury J

Authors: Tannoury J, Mule S, Chayale J, Luciani A, Ette E,

Keywords: PET, MRI, GIT-NET,

#2080 Linked Colour Imaging Increases the Diagnostic Yield of Type 1 Gastric Carcinoid

Introduction: Type 1 Gastric carcinoid tumours (GCTs) are the most common neuroendocrine tumours of the stomach. Endoscopic diagnosis of Type 1 GCTs remains a challenge. White light endoscopy (WLE) and Narrow Band Imaging (NBI) have failed to demonstrate reliable endoscopic signs of carcinoid.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Gulati S

Authors: Gulati S, Srirajaskanthan R, Ramage J, Emmanuel A, Haji A,

Keywords: gastric carcinoid, endoscopy, surveillance, therapy,

#2077 Linked Colour Imaging Increases the Diagnostic Yield of Type 1 Gastric Carcinoids

Introduction: Type 1 Gastric carcinoid tumours (GCTs) are the most common neuroendocrine tumours of the stomach. Endoscopic diagnosis of Type 1 GCTs remains a challenge. White light endoscopy (WLE) and Narrow Band Imaging (NBI) have failed to demonstrate reliable endoscopic signs of carcinoid.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Gulati S

Authors: Gulati S, Sriraja R, Ramage J, Emmanuel A, Haji A,

Keywords: gastric carcinoid, gastric neuroendocrine tumors, endoscopy, therapy, surveillance, polypectomy, endoscopic resection,

#1590 Treatment of Metastatic Pancreatic Neuroendocrine Tumors: Relevance of ENETS 2016 Guidelines

Introduction: The choice of first-line treatment of metastatic pancreatic neuroendocrine tumors (mP-NET) is mainly based on prognostic factors. ENETS-2016 guidelines proposed treatments according to 3 groups: Group-1, patients in whom all lesions could be removed; Group-2, patients with Ki67<10%, low tumor burden, no symptoms, and stable disease, for whom a watch-and-wait strategy or somatostatin analogs are proposed; Group-3, symptomatic patients or with Ki67>10% or significant tumor burden or progressive disease, for whom a systemic chemotherapy is proposed

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Foulfoin M

Authors: Foulfoin F, Graillot E, Adham M, Rousset P, Forestier J,

Keywords: pancreas, metastasis,

#900 Renal Effects of Streptozocin: Preliminary Results of the STREPTOTOX Study

Introduction: Based on old studies, Streptozocin (STZ) is known to have some renal toxicity.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Mitry E

Authors: Mitry E, Brixi H, Lecomte T, Lombard-Bohas C, Seitz J,

Keywords: digestive neuroendocrine tumors, streptozotocin, nephrotoxicity, chemotherapy,